Comments

BioCryst Pharma Stock Price, Quotes and Forecasts

Q: What sector and industry does BioCryst Pharma (BCRX) operate in?

BioCryst Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

BCRXNASDAQ

BioCryst Pharma (BCRX) Forecast

News Earnings BioCryst Pharma (BCRX) Options Guidance Dividends Analyst Ratings Insider Trades Government Trades Short Interest

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

BioCryst Pharma Stock Price, Quotes and Forecasts | NASDAQ:BCRX | Benzinga

Explore BioCryst Pharma stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for BCRX.

Open	$8.14
Close	-
Volume / Avg.	4.11M / 2.71M
Day Range	$7.67 - $8.34
52 Wk Range	4.03 - 9.50
Market Cap	$1.74B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	47
Short Interest	8.04%
Days to Cover	5.62

Recent News

BioCryst Pharmaceuticals Unveils Latest Trial Data, Reports Mixed Q4 Earnings

BioCryst's Orladeyo showed sustained HAE attack reductions in real-world data. The company expects positive EPS and cash flow in the second half of 2025.

Vandana Singh

Why Bolt Biotherapeutics Shares Are Trading Lower By Around 34%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

Avi Kapoor

NEXTracker Posts Upbeat Earnings, Joins monday.com, Nu Holdings And Other Big Stocks Moving Higher On Wednesday

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Nov 24

Dec 24

Jan

Feb

Mar

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$8.14
Close	-
Volume / Avg.	4.11M / 2.71M
Day Range	$7.67 - $8.34
52 Wk Range	4.03 - 9.50
Market Cap	$1.74B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	47
Short Interest	8.04%
Days to Cover	5.62

About Biocryst Pharmaceuticals Inc.

Sector

Health Care

Industry

Biotechnology

BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and developm...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy BioCryst Pharma (BCRX) stock?

You can purchase shares of BioCryst Pharma (NASDAQ:BCRX) through any online brokerage.

View our list of the best stock brokerages

Who are BioCryst Pharma (BCRX) competitors?

Other companies in BioCryst Pharma’s space includes: IDEAYA Biosciences (NASDAQ:IDYA), 89bio (NASDAQ:ETNB), Centessa Pharmaceuticals (NASDAQ:CNTA), Ascentage Pharma Group (NASDAQ:AAPG) and Syndax Pharmaceuticals (NASDAQ:SNDX).

What is the forecast, or price target, for BioCryst Pharma (BCRX) stock?

BioCryst Pharma has a consensus price target of $14.30.

What is the current price for BioCryst Pharma (BCRX)?

The stock price for BioCryst Pharma (NASDAQ: BCRX) is $8.32 last updated March 4, 2025 at 1:45 PM EST.

Does BioCryst Pharma (BCRX) pay a dividend?

There are no upcoming dividends for BioCryst Pharma.

When is BioCryst Pharma (NASDAQ:BCRX) reporting earnings?

BioCryst Pharma’s Q1 earnings are confirmed for Monday, May 5, 2025.

Is BioCryst Pharma (BCRX) going to split?

There is no upcoming split for BioCryst Pharma.

What sector and industry does BioCryst Pharma (BCRX) operate in?

BioCryst Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.